Severe Refractory Atopic Dermatitis in an Adolescent Patient Successfully Treated with Ustekinumab
Open accessThe DOI matches its Crossref record.
Abstract
Although controlled clinical trials will be required to establish the effectiveness of ustekinumab in AD, we suggest that ustekinumab might be a useful and safe treatment of refractory AD in young patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Noda, S., Suárez-Fariñas, M., Ungar, B., Kim, S. J., de Guzman Strong, C., Xu, H., Peng, X., Estrada, Y. D., Nakajima, S., Honda, T., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.015 · Cited by 657
The Role of Th17-Related Cytokines in Atopic Dermatitis
Sugaya, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041314 · Cited by 204
“A 16-year-old woman with over a 13-year history of severe AD was also reported to show clearance of severe itch after one injection of ustekinumab 45 mg, although it had been resistant to phototherapy and systemic agents such as cyclosporine and azathioprine [51].”
BackgroundNovel Biologicals for the Treatment of Allergic Diseases and Asthma
Tan, H.-T. T., Sugita, K., & Akdis, C. A. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0650-5 · Cited by 68
Metadata
- Authors
- Agusti-Mejias, A., Messeguer, F., García, R., & Febrer, I.
- Venue
- Annals of Dermatology
- Published
- 2013
- Volume
- 25
- Issue
- 3
- Pages
- 368
- ISSN
- 1013-9087 (ISSN-L)
- 2005-3894
- OpenAlex
- W2043082699
- Cited by
- 44
- References
- 0
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Severe Refractory Atopic Dermatitis in an Adolescent Patient Successfully Treated with Ustekinumab. https://app.cochat.ai/papers/10.5021/ad.2013.25.3.368
- The paper
- Agusti-Mejias, A., Messeguer, F., García, R., & Febrer, I. (2013). Severe Refractory Atopic Dermatitis in an Adolescent Patient Successfully Treated with Ustekinumab. Annals of Dermatology. https://doi.org/10.5021/ad.2013.25.3.368
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.